Read + Share
Luo YH, Liu H, Wampfler JA, Tazelaar HD, et al. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients
without identification of T790M mutation. J Cancer Res Clin Oncol 2022;148:2099-2114.
PMID: 34436667
|
 |
|
Luo YH, Liu H, Wampfler JA, Tazelaar HD, et al. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients
without identification of T790M mutation. J Cancer Res Clin Oncol 2022;148:2099-2114.
PMID: 34436667
|
|
|
|